| Execution period | Vesting over 4 years; exercise period up to 7 years |
|---|
BSE filing, NSE: XELPMOC. Summary written from the filing by ALFA Finder's alert engine.
Xelpmoc Design and Tech Ltd: key numbers
- Share price
- ₹76.95
- Market cap
- ₹114.1 Cr
- Revenue (annual)
- ₹3.74 Cr
- Net profit (annual)
- ₹-7.59 Cr
- P/E (TTM)
- -14.4×Sector 22.9×
- Promoter holding
- 48.71%-0.68% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Xelpmoc Design and Tech Ltd
All →Xelpmoc Design and Tech Other Announcement
The company filed its quarterly shareholding pattern as mandated under SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Xelpmoc Design and Tech Price Movement Clarification
Xelpmoc Design and Tech told exchanges it has disclosed all material information and withheld nothing. No unpublished price-sensitive information explains the observed price movement.
Xelpmoc Design and Tech Annual General Meeting
Xelpmoc Design and Tech Limited held its 11th Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, and new ESOP schemes.
Xelpmoc Design and Tech Employee Stock Options
Xelpmoc allotted 8,400 equity shares at Rs.10 per option to employees under its ESOP 2019 scheme. Paid-up capital rose to ₹14.83 Crore post-allotment.
Xelpmoc Design and Tech Merger & Restructuring Worth ₹14.58 Cr
Xelpmoc Design and Tech Ltd has approved the sale of its equity stake in Woovly India Private Limited for a total consideration of ₹14.58 Crore.
- Value
- ₹14.58 Cr
Xelpmoc Design and Tech Annual General Meeting
Xelpmoc Design and Tech Ltd scheduled its 11th Annual General Meeting for September 30, 2026. Agenda items include financial statement adoption and new ESOP scheme approvals.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.